Elevance Health
In Glenn Greenberg's portfolio · Brave Warrior Advisors
Ticker ELV
Still in the portfolio as of Q2 2026. Every quarter it shows up in a Brave Warrior Advisors 13F, newest first.
| Quarter | Activity | Shares | Weight |
|---|---|---|---|
| Q2 2026 | Reduce 13% | 976,885 | 8.2% |
| Q1 2026 | Reduce 10% | 1,122,308 | 8.1% |
| Q4 2025 | Reduce 32% | 1,251,803 | 10.3% |
| Q3 2025 | Add 65% | 1,834,002 | 13.8% |
| Q2 2025 | Reduce 30% | 1,109,653 | 9.9% |
| Q1 2025 | Reduce 3% | 1,577,570 | 15.7% |
| Q4 2024 | Reduce 1% | 1,629,977 | 15.0% |
| Q3 2024 | Add 1% | 1,641,413 | 17.7% |
| Q2 2024 | Reduce 1% | 1,633,127 | 19.6% |
| Q1 2024 | Reduce 6% | 1,645,837 | 17.9% |
| Q4 2023 | Add 8% | 1,756,653 | 19.8% |
| Q3 2023 | Add 23% | 1,627,598 | 17.7% |
| Q2 2023 | Add 22% | 1,321,272 | 15.5% |
| Q1 2023 | Add 24% | 1,084,768 | 15.4% |
| Q4 2022 | Reduce 27% | 872,415 | 14.1% |
| Q3 2022 | Reduce 2% | 1,189,871 | 18.7% |
| Q2 2022 | Reduce 10% | 1,211,276 | 20.1% |
| Q1 2022 | Reduce 1% | 1,353,249 | 19.6% |
| Q4 2021 | No change | 1,365,785 | 20.2% |
| Q3 2021 | Add 20% | 1,371,262 | 17.9% |
| Q2 2021 | Reduce 2% | 1,145,416 | 15.0% |
| Q1 2021 | Add 51% | 1,163,729 | 13.6% |
| Q4 2020 | Add 1% | 771,135 | 9.1% |
| Q3 2020 | Reduce 1% | 763,927 | 9.2% |
| Q2 2020 | Reduce 12% | 771,468 | 10.1% |
| Q1 2020 | Add 39% | 875,467 | 11.4% |
| Q4 2019 | Reduce 2% | 627,652 | 10.0% |
| Q3 2019 | Buy | 638,397 | 8.2% |
Price is the position's value divided by its shares, at the end of each quarter. Share counts are as filed; when a stock split happened, the change is measured on split-adjusted shares.